- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04449848
The Effect of Patient's Position After Intra-tympanic Injection on the Amount of Fluid in the Middle Ear
June 26, 2020 updated by: Tel-Aviv Sourasky Medical Center
During the regular protocol of Intra-tympanic injections of Dexamethasone to the middle ear due to Sudden Sensorineural Hearing Loss, the patients will be sitted once after the injection instead of lying down.
They will be then asked to rate their taste as a reference to the amount of fluid leaking to the throat through the eustachian tube.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yahav Oron, MD
- Phone Number: +97236973573
- Email: oron.yahav@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients diagnosed with Sudden Sensorineural Hearing Loss, treated using intra-tympanic injection of steroids to the middle ear
Exclusion Criteria:
- Patients with abnormal sense of taste
- Middle or inner ear anomaly
- Eustachian tube dysfunction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sitting after intra tympanic injection
Patients with Sudden hearing loss sitting after intra tympanic injection of steroids
|
Sitting after intra tympanic injection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bitter taste
Time Frame: 30 minutes
|
Bitter taste described by the patients using a questionnaire with a scale of 0 to 5
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2020
Primary Completion (Anticipated)
July 31, 2021
Study Completion (Anticipated)
July 31, 2021
Study Registration Dates
First Submitted
June 24, 2020
First Submitted That Met QC Criteria
June 26, 2020
First Posted (Actual)
June 29, 2020
Study Record Updates
Last Update Posted (Actual)
June 29, 2020
Last Update Submitted That Met QC Criteria
June 26, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0182-20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sudden Hearing Loss
-
Sheba Medical CenterUnknown
-
Peking University People's HospitalUnknownFull-frequency Sudden Hearing Loss
-
Eye & ENT Hospital of Fudan UniversityCompletedVestibular Disorder | Sudden Hearing LossChina
-
Second Affiliated Hospital, School of Medicine,...UnknownDexamethasone or Methylprednisolone; Sudden Hearing Loss; Intratympanic Steroid
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Eye & ENT Hospital of Fudan UniversityUnknownSudden Hearing Loss | Vestibular VertigoChina
-
Dan BingNot yet recruitingHearing Loss, Sensorineural | Sudden Sensorineural Hearing Loss | Hearing Loss, Sudden
-
Tel-Aviv Sourasky Medical CenterUnknownSudden Hearing Loss
Clinical Trials on Sitting after intra tympanic injection
-
Tel-Aviv Sourasky Medical CenterUnknownSudden Hearing Loss
-
Dalia Salah SaifUnknownRA - Rheumatoid ArthritisEgypt
-
Istanbul UniversityRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedTympanic Membrane Perforation | TempanoplastyFrance
-
Centro de Infertilidad y Reproducción HumanaTerminated
-
St George's, University of LondonWellcome Trust; Rosetrees TrustUnknownRheumatoid Arthritis | Osteoarthritis, Knee | Psoriatic Arthritis | SpondyloarthritisUnited Kingdom
-
Ziv HospitalUnknownOtotoxicity | Cisplatin | Intratympanic SteroidsIsrael
-
Sisli Hamidiye Etfal Training and Research HospitalCompleted
-
University Hospital TuebingenUnknownJuvenile Idiopathic ArthritisGermany
-
Anna OlczakCompletedStroke, IschemicPoland